French microbiologist hopes CRISPR/Cas9 can be used medically
Berlin, June 19 (CNA) French microbiologist Emmanuelle Charpentier, who was named a co-winner of the second Tang Prize in biopharmaceutical science on Sunday for her work in the development of CRISPR/Cas9, said she hopes the genome editing technology can be used to treat currently incurable conditions.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Taiwan reports one new domestic COVID-19 case from hospital01/16/2021 11:31 PM
Taiwan shuttlers reach finals at Yonex Thailand Open01/16/2021 10:33 PM
Taiwanese fishing boat rescues crewmen from distressed freighter01/16/2021 10:24 PM
Hon Hai to increase number of 'lighthouse' factories in China01/16/2021 09:56 PM
Taiwan, U.S. diplomats meet after official contact ban lifted01/16/2021 09:48 PM